PATENT CLAIM ANALYSIS

Application Number: 15923469
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "497000"]

Abstract:
The present invention relates to pediatric drug formulation. Especially, this invention relates to the manufacturing of granules comprising a core comprising a drug having an unpleasant taste, which may be a primary bile acid, such as for example cholic acid, and a taste-masking coating. The purpose of the invention is to fully mask unpleasant taste of the drug, while ensuring its availability at the duodenum biological site.

Claim (Index 10):
Granule according to  claim 1 , comprising:\n from 30% to 50% in weight relative to the total weight of the granule of cholic acid; from 10% to 20% in weight relative to the total weight of the formulation of mannitol; from 10% to 20% in weight relative to the total weight of the formulation of microcrystalline cellulose; from 0.5% to 5% in weight relative to the total weight of the formulation of polyvinylpyrrolidone; from 20% to 40% in weight relative to the total weight of the formulation of Poly(butyl methacrylate-co-(2-dimethylaminoethyl) methacrylate-co-methyl methacrylate) (1:2:1).

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.53061
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14384210', '13933323', '12376060', '14889009', '13166770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6889245619099904
- 35 USC 102 Novelty (BERT): 0.4994271989376898
- Combined Prediction Score: 0.6699748256127603
- Mean Citation Score: 215.20237200000005
- Max Citation Score: 229.28883
- Similarity Product: 153.65770029150724

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test